Stocks and Investing
Stocks and Investing
Mon, November 14, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Matthew Harrison Maintained (VIGL) at Hold with Increased Target to $12 on, Nov 14th, 2022
Matthew Harrison of Morgan Stanley, Maintained "Vigil Neuroscience, Inc." (VIGL) at Hold with Increased Target from $11 to $12 on, Nov 14th, 2022.
Matthew has made no other calls on VIGL in the last 4 months.
There are 3 other peers that have a rating on VIGL. Out of the 3 peers that are also analyzing VIGL, 0 agree with Matthew's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Matthew
- Yatin Suneja of "Guggenheim" Maintained at Strong Buy with Decreased Target to $19 on, Friday, November 11th, 2022
- Laura Chico of "Wedbush" Initiated at Buy and Held Target at $19 on, Friday, September 16th, 2022
- Andrew Fein of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $24 on, Monday, August 29th, 2022
Contributing Sources